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Glial choristoma of the tongue is a rare developmental anomaly usually occurring 
in the first two years of life. Although diverse theories have been suggested to ex-
plain its development, they do not seem to take into account the normal tongue 
development. We report here on a glial choristoma of the tongue in a two-month-
old male with the aim to describe the clinicopathological features of this lesion and 
to discuss the pathogenetic role of the cells that normally migrate from the cranial 
neural crests to generate the ectomesenchymal derivatives of the tongue and ex-
press neuroglial differentiation as normal developmental pathway.
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Introduction
The term choristoma is used to indicate a cohesive 
tumour-like mass consisting of normal cells in an ab-
normal location [1]. Glial choristoma, which is a cho-
ristoma composed by glial cells either in association or 
not with other normal brain tissue elements, is more 
commonly restricted to the craniofacial region where 
the tongue is rarely involved [2, 3, 4, 5, 6, 7, 8, 9, 10, 
11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 
25, 26, 27, 28, 29]. Even though different terms have 
been used to define the lesion, including glioma [3, 
4, 16], glial/gliomatous teratoma [5, 10], heterotopic 
brain, or neural/glial/neuroglial tissue [6, 7, 8, 9, 11, 
24, 28], the term glial choristoma is more appropriate 
because the lesion is a developmental anomaly and not 
a neoplasm and produces a tumour-like tissue mass [1, 
2]. Surgical excision with free margins is curative and, 
because the lesion may be only suspected at clinical 
examination, histology and immunohistochemistry 
are mandatory for the definitive diagnosis [13, 15, 17, 
18, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30].
The pathogenetic mechanism leading to the de-
velopment of the glial choristoma in the craniofacial 
region is not known, and different pathogenetic theo-
ries have been suggested [1, 5, 11, 13, 16, 17, 18, 19, 
21, 23, 25, 26, 27, 28, 30, 31]. Of note, a potential 
role of the cells normally emanating from the cra-
nial neural crests (CNCs), which are involved in the 
development of the ectomesenchymal components of 
the human head including the tongue and express 
neuroglial differentiation as a normal developmental 
pathway [32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 
43, 44], has been virtually never taken into account 
[1, 18, 30, 31].
We report here the clinicopathological features 
of a glial choristoma of the tongue in a two-month-
old male and reviewed the pertinent literature. As 
a previously unreported finding, we observed that 
rare lesional cells were immunoreactive for both 
a-smooth muscle actin (a-SMA) and glial fibrillary 
acidic protein (GFAP). Based on the presence of these 
cells, which probably represent partially committed 
CNC-derived cells, we discuss the potential origin of 
glial choristoma of the tongue from the abnormal dif-
ferentiation of orthotopically migrated CNC-derived 
cells toward a neural rather than ectomesenchymal 
derivative as normally occurs. 
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Material and methods
Clinical history
A well-circumscribed, firm, sub-mucosal mass 
was excised from the dorsum of the tongue of a two-
month old boy who presented with a brief history 
of breathing and feeding difficulty. Available clinical 
data included the absence of other oral abnormalities 
and enlargement of neck lymph-nodes. Magnetic res-
onance revealed a mass, 2.5 cm in largest dimension, 
located on the dorsal surface of the tongue. The mass 
was completely excised with a margin of lingual mus-
cular tissue. The post-operative course was referred 
as uneventful. At eight months post-surgery a fol-
low-up was performed in which the patient remained 
free from recurrence. 
Pathological analysis
The resected specimen was routinely fixed with 
4% formalin and processed for paraffin embedding. 
Five-mm-thick sections were stained with Haematox-
ylin-Eosin and Sirius Red and immunostained with 
diverse antisera including: Glial Fibrillar Acidic Pro-
tein (GFAP, 6F2, 1 : 50; Dako, Glostrup, Denmark), 
S100 (1 : 1000; Dako), a-Smooth Muscle Actin 
(a-SMA, 1A4, 1 : 300; Dako), EMA (E29, 1 : 50, 
Dako), Neurofilament (NF, 2F11, 1 : 50; Dako), 
CD68R (PG-M1, 1 : 50, Dako) and Ki67 (Mib1, 
1 : 100, DBA Italia, Segrate, Italy). Microwave oven 
treatment (three times for five minutes in 0.01 M so-
dium citrate, pH 6) was performed before immunos-
taining with EMA, NF, CD68R and Ki67 antisera. 
Double immunostaining was performed as well by 
means of a two-step procedure using first antiserum 
to a-SMA, LSAB+System-HRP kit (Dako), and 
3,3’-diaminobenzidine tetrahydrochloride (Sigma, 
St Louis, MO, USA) as substrate and then antiserum 
to GFAP, FMR4-61kit (Biospa, Milan, Italy), and 
5-Bromo-4-chloro-3 indolyl-phoshate/4-Nitro blue 
tetrazolium chloride (Roche Diagnostics GmbH, 
Mannheim, Germany) as substrate. 
Results
Histological examination of the resected specimen 
(Fig. 1A) revealed a sub-mucosal mass composed of 
mature brain tissues (Fig. 1B, E). A fibro-vascular 
framework was evident and clearly highlighted by 
Sirius Red stain (Fig. 1C, D). Cell pleomorphism, mi-
tosis, and necrosis were absent. Some mucosal glands 
were detected at the top of the lesion (Fig.1B, C) and 
interpreted as orthotropic normal structures. Gli-
al cells and their fibrillary network were immunos-
tained with GFAP (Fig. 2A) and S100 (Fig. 2B) an-
tisera. NF immunohistochemistry identified neurons 
and axons (Fig. 2C). Histiocyte-like cells (microglia) 
were also identified based on their immunoreactivity 
for CD68R (Fig. 2D). The intra-lesional absence of 
immunoreactivity for EMA excluded the presence of 
meningeal-like tissue. Immunostaining for a-SMA 
highlighted the fibrovascular framework and rare 
lesional cells (Fig. 2E) were also immunostained. In-
terestingly, isolated a-SMA-positive cells were also 
immunostained with GFAP (Fig. 2F, G). The pro-
liferation index, evaluated by Ki67 immunostaining, 
was low (< 1%). 
Discussion
Because of its rarity, any single case of glial cho-
ristoma of the tongue can be a diagnostic clinical 
challenge and may offer the opportunity to discuss 
the pathobiological mechanisms involved in its de-
velopment. From a clinical point of view, the differ-
ential diagnosis of glial choristoma of the tongue is 
extremely huge and includes reactive, malformative, 
and neoplastic lesions. No more than 30 cases have 
been reported since 1922, when Peterer [3] described 
the first case in a 6-week-old female. The age at diag-
nosis has been reported to range from birth [9] to 28 
years [21] without significant gender difference and 
with a significant predominance in the first two years 
of life. The dorsum of the tongue is the most fre-
quently involved site. The lesion has been described 
isolated in all cases except one in which cleft palate, 
ventricle septum defect, and patent ductus arteriosus 
were also present [26]. Feeding difficulty, dyspha-
gia, and respiratory distress are the most common 
presenting syndrome. As in the case reported here, 
conservative complete surgical excision is curative. In 
two cases, incomplete excision was followed by local 
recurrence, and re-excision was curative [3, 9]. His-
tologically, all the lesions shared glial tissue. In some 
cases, other brain tissue elements, in including neu-
rons, ependymal-like epithelium, and choroid plex-
us-like structures were also detected in variable com-
bination and proportion [5, 6, 7, 8, 11, 13, 15, 17, 
19, 20, 21, 25, 26]. In one case [25], meningeal-like 
tissue was detected as well. Thus, the case reported 
here fulfils the clinicopathological criteria for the di-
agnosis of glial choristoma of the tongue.
The pathogenetic mechanism leading to the de-
velopment of the glial choristoma in the tongue is 
not known. No specific syndromic predisposition or 
aetiological factors have been identified. According 
to the most widely diffused theory, which has been 
repeatedly cited and handed down in time till to the 
most recently published papers [25, 26, 27, 28, 29], 
glial choristoma of the tongue is thought to derive 
from the differentiation towards neural tissue of ei-
ther pluripotent embryonic remnants or displaced 
neuroectodermal/pluripotent cells that separate be-
fore the complete fusion of the neural tube and in-
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Fig. 1. Whole mount histology of the excised sample is 
illustrated in A. The lesion shows an expansile pattern of 
growth and does not involve the overlying squamous ep-
ithelium. A fibro-vascular framework separates irregular 
lobules of mature brain tissue (B-E). The arrows in B and 
C identify orthotopic mucosal glands at the periphery of 
the lesion. Panel A, B, and E: Haematoxylin-Eosin. Panel 
C and D: Sirius Red. Bar: 200 mm in B and C; 100 mm in 
D; 50 mm in E
tegrate with the myogenic precursors that migrate 
from the occipital somites to the tongue primordi-
um, where they give rise to lingual muscle. However, 
these theories do not seem to take into account the 
normal development of the tongue and the multipo-
tent capacity of the CNC derived cells which are pri-
marily involved in this process. Normally, the tongue 
starts to develop at the end of the fourth week with 
the formation of multiple swellings on the floor of the 
pharynx, which are produced by cells that migrate 
from the CNC into the branchial arches, in partic-
ular the first one [32]. During and after migration, 
these cells contribute to the development of most of 
the craniofacial structures, generating, based on the 
effect of specific genetic and epigenetic factors and 
according to a hierarchical model of lineage segre-
gation, a very wide range of ectomesenchymal and 
neural derivatives [33, 34, 35, 36, 37, 38, 39, 40, 
41, 42, 43, 44]. Several syndromes and congenital 
conditions termed neurocristopathies, which include, 
among others, DiGeorge syndrome, Waardenburg 
syndrome, and craniofacial microsomia, are well 
known to be related to reduced survival and improp-
er migration of these cells [45, 46, 47]. Specifical-
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Fig. 2. Diffuse immunoreactivity of lesional cells and fibrillary network for GFAP and S100 are illustrated in A and B, 
respectively. Immunostains for NF and CD68R highlight neurons (C) and histiocyte-like cells (D), respectively. Rare in-
tra-lesional cells are immunoreactive for a-SMA (E) and some of them for GFAP as well (arrows, F and G). Bar: 100 mm 
in A-E; 50 mm in F and G
F G
ly, in the tongue, these cells normally provide to the 
generation of the ectomesenchymal cell populations 
(connective tissue cells, smooth muscle cells, and vas-
culature) that a) act as a scaffold for the myogenic 
progenitors migrating from the occipital somites and 
b) provide the molecular instruction to direct their 
survival, proliferation, and differentiation towards 
the lingual muscles [32]. Thus, based on the role of 
CNC-derived cells in the normal tongue organogen-
esis and on their multipotent differentiation capaci-
ty, glial choristoma of the tongue may be reasonably 
re-thought as the result of a normal, but heterotop-
ic, differentiation toward neural derivatives of the 
migratory or post-migratory CNC-derived cells in-
volved in the generation of the ectomesenchymal an-
lagen of the tongue. The cells co-expressing a-SMA 
and GFAP identified in our case may represent un-
committed CNC progenitors that, as normally occurs 
in vivo in the developing orthotopic brain [48], go on 
to differentiate heterotopically into astrocytes. Trans-
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lated in the clinical scenario, it can be assumed that 
once the differentiation towards neural derivatives 
has occurred, the cell population will expand in par-
allel with the growth of the normal orthotopic brain, 
which is faster in the first two years of life, which is 
the age range in which glial choristoma of the tongue 
is more commonly diagnosed.
In conclusion, we reported here the clinicopatho-
logical features of a rare case of glial choristoma of the 
tongue and provide an alternative explanation of its 
pathogenesis according to which glial choristoma of 
the tongue may develop from the cells that normally 
emanate from the CNC and differentiate heteroto-
pically toward neural rather than ectomesenchymal 
as normally occurs in the normal development of the 
tongue. The occurrence of glial choristoma in adult-
hood [21] does not contrast with our hypothesis be-
cause multipotent CNC-derived cells have been re-
ported to persist until adulthood [40, 42, 43, 44]. 
The authors declare no conflict of interest.
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